The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches

Author:

Lobbezoo Dorien12,Truin Wilfred13,Voogd Adri1,Roumen Rudi13,Vreugdenhil Gerard12,Dercksen Marcus Wouter2,van den Berkmortel Franchette4,Smilde Tineke5,van de Wouw Agnes6,van Kampen Roel17,van Riel Johanna8,Peters Natascha9,Peer Petronella10,Tjan-Heijnen Vivianne C.G.1

Affiliation:

1. GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands

2. Department of Internal Medicine, Máxima Medical Center, Veldhoven, The Netherlands

3. Department of Surgery, Máxima Medical Center, Veldhoven, The Netherlands

4. Department of Internal Medicine, Atrium-Orbis, Heerlen, The Netherlands

5. Department of Internal Medicine, Jeroen Bosch Hospital, Den Bosch, The Netherlands

6. Department of Internal Medicine, VieCuri Medical Center, Venlo, The Netherlands

7. Department of Internal Medicine, Atrium-Orbis, Sittard, The Netherlands

8. Department of Internal Medicine, St Elisabeth Hospital, Tilburg, The Netherlands

9. Department of Internal Medicine, St Jans Hospital, Weert, The Netherlands

10. Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3